---
title: "Clinical data of COVID-19 infected patients"
author: "Group 05 - Daniel Gil, Luis Martín, Miguel Blanco, Natalia Feced, Xavi Chapatte"
format: 
  revealjs:
    height: 900
    width: 1600
    theme: simple
    transition: none
    slideNumber: true

editor: visual
subtite: "A case of study for critically ill patients"
css: styles.css
---

## Introduction

**Covid-19**\

::: {style="font-size: 40px;"}
-   Caused by the [**SARS-CoV-2 virus**]{.fragment .highlight-red}, with varying severity globally.
-   [**Symptoms**]{.fragment .highlight-red} include: fever, cough, myalgia, fatigue, and severe respiratory failure in critical cases.
:::

::: nonincremental
**Vaccines and Antiviral drugs**\

-   [**Vaccines**]{.fragment .highlight-red} have reduced the global burden of COVID-19 significantly.
-   Before widespread vaccination, [**antivirals**]{.fragment .highlight-red} played a key role in severe cases.
-   [**Paxlovid**]{.fragment .highlight-red} (SARS-CoV-2 main protease inhibitor) and [**Azduvine**]{.fragment .highlight-red} emerged as a promising treatments, reducing severe outcomes and mortality.
:::

::: footer
Article 1 - ScienceDirect\
Article 2 - PMC\]
:::

## Materials - Dataset

::: {.column width="40%"}
::: {style="font-size: 39px; text-align: justify;"}
\

-   [**Clinical data**]{.fragment .highlight-red} from a medical center in China between December 2022 - January 2023.
-   Dataset with a final number of 123 [**variables**]{.fragment .highlight-red} and 150 [**observations**]{.fragment .highlight-red}.
-   Researchers concluded [**Paxlovid**]{.fragment .highlight-red} significantly improved patient outcomes.
-   [**Our aim**]{.fragment .highlight-red}: Test the conclusion on publicly available data
-   Explore parameters contributing to [**survival**]{.fragment .highlight-red} or [**death**]{.fragment .highlight-red}.
:::
:::

::: {.column width="27%"}
**Table 1**\
<iframe src="../results/table1_describe_01.html" width="100%" height="300"></iframe>\
**Diseases**\
<iframe src="../results/table1_describe_02.html" width="100%" height="300"></iframe>
:::

::: {.column width="28%"}
**Table 2**\
<iframe src="../results/table1_describe_04.html" width="100%" height="300"></iframe>\
**Symptoms**\
<iframe src="../results/table1_describe_03.html" width="100%" height="300"></iframe>
:::

------------------------------------------------------------------------

## Methodology

::: row
::: {.column width="49%"}
::: fragment
### Data Clean {style="font-size: 38px;"}

::: nonincremental
::: {style="font-size: 26px;"}
-⁠ ⁠**Unify** missing values notation (NA values)

-⁠ ⁠**Remove** columns with more than 70% NAs

-⁠ ⁠**Adjust** variables names

-⁠ ⁠**Column-specific changes** (removing non-numerical final characters)
:::
:::
:::
:::

::: {.column width="49%"}
::: fragment
### Data Augment {style="font-size: 38px;"}

::: nonincremental
::: {style="font-size: 26px;"}
-   ⁠**Change dirty columns** to binary-values columns
-   ⁠**Change (some) numeric values to more descriptive values**
-   ⁠**Polish** binary values
-   ⁠**Create new variables** (Mean_Age, Early/Late_Onset, Sum_Basic_Diseases ...)
:::
:::
:::
:::
:::

::: row
::: {.column width="100%"}
<figure>![](images/messy_dataset.png)</figure>
:::
:::

------------------------------------------------------------------------

## Analysis Planning

::: {.absolute-container style="position: relative; width: 100%; height: 100%;"}
::: fragment
### Initial Exploration {style="position: absolute; top: 8%; left: 9%; font-size: 50px;"}

#### What variables we think are more related to the Outcome? {style="position: absolute; top: 15%; left: 1%; font-size: 28px;"}
:::

::: fragment
### Statistical Exploration {style="position: absolute; top: 33%; left: 59%; font-size: 50px;"}

#### What variables are statistically more related to the Outcome? {style="position: absolute; top: 40%; left: 50%; font-size: 28px;"}
:::

::: fragment
### Paxlovid Exploration {style="position: absolute; top: 62%; left: 30%; font-size: 50px;"}

#### Can we get the same conclusion about the Paxlovid efficacy with this data? {style="position: absolute; top: 69%; left: 17%; font-size: 28px;"}
:::
:::

------------------------------------------------------------------------

## Data Description

### Factors Influencing Mortality: Overview

\

::: rows
::: columns
::: {.column width="33%"}
<figure>![](images/05_key_plot_1-02.png){width="800"}</figure>
:::

::: {.column width="33%"}
<figure>![](images/05_key_plot_3-02.png){width="800"}</figure>
:::

::: {.column width="33%"}
<figure>![](images/05_key_plot_7-02.png){width="800"}</figure>
:::
:::
:::

------------------------------------------------------------------------

## Data Description

### Factors Influencing Mortality: Overview

\

::: rows
::: columns
::: {.column width="33%"}
<figure>![](images/05_key_plot_4-02.png){width="800"}</figure>
:::

::: {.column width="33%"}
<figure>![](images/05_key_plot_5-02.png){width="800"}</figure>
:::

::: {.column width="33%"}
<figure>![](images/05_key_plot_6-02.png){width="800"}</figure>
:::
:::
:::

------------------------------------------------------------------------

## Analysis

### Statistical analysis and modelling

::: columns
::: {.column width="49%"}
To examine the relationship between each variable and the outcome, we fit **logistic regression models** and evaluate the estimates. These estimates indicate the strength and direction of association between each variable and the outcome.

\

```{r, eval=FALSE, echo=TRUE}
results <- data_numeric |> 
  select(-Death) |>  
  # Pivot longer to have one variable per row
  pivot_longer(cols = everything(), 
               names_to = "variable", 
               values_to = "value") |> 
  group_by(variable) |> 
  # Fit model
  summarise(
    model = list(glm(Death ~ value, 
                     data = data, family = binomial))
    )
    
```
:::

::: {.column width="49%"}
<figure>![](../results/05_esimate_size_plot.png)</figure>
:::
:::

------------------------------------------------------------------------

## Analysis

### Statistical analysis and modelling

::: columns
::: {.column width="49%"}
-   In the logistic regression model, we found that the **Lymphocytes** count at day 7 is the variable that better determines the outcome.

-   Can the treatment with **Paxlovid** modify the Lymphocytes level?

\

```{r, eval = FALSE, echo=TRUE}
wilcox.test(
  `D7_lymphocyte_count[10^9/L]` ~ 
    `Antiviral_drugs_(1_nema_0_no)`,
  data = data
)
```
:::

::: {.column width="49%"}
<figure>![](../results/05_esimate_size_plot.png)</figure>
:::
:::

## Analysis

### Statistical analysis and modelling

::: columns
::: {.column width="49%"}
-   In the logistic regression model, we found that the **Lymphocytes** count at day 7 is the variable that better determines the outcome.

-   Can the treatment with **Paxlovid** modify the Lymphocytes level?

\

```{r, eval = FALSE, echo=TRUE}
wilcox.test(
  `D7_lymphocyte_count[10^9/L]` ~ 
    `Antiviral_drugs_(1_nema_0_no)`,
  data = data
)
```
:::

::: {.column width="49%"}
<figure>![](../results/05_esimate_size_plot.png)</figure>
:::
:::

## Analysis

### Paxlovid Exploration

::: columns
::: {.column width="50%"}
<figure>![](images/05_key_plot_6-02.png)</figure>
:::

::: {.column width="50%"}
<figure>![](images/05_key_plot_6-02.png)</figure>
:::
:::

------------------------------------------------------------------------

### Discussion and Conclusion

::: {style="margin-top: 100px;"}
:::

::: nonincremental
-   In the dataset no difference can be seen in the outcome regarding the antiviral treatment.

\

-   The lymphocyte count in day 7 is the factor that mostly improves survival in the dataset.

\

-   The biological problem has to be thought as complex and interconnected, so no easy conclusion can be obtained and more studies may be needed.
:::
